<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>11</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2012</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Effects of MnTnHex-2-PyP on Lung Antioxidant Defence System in Asthma Mice Model</title>
    <FirstPage>329</FirstPage>
    <LastPage>335</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Violeta</FirstName>
        <LastName>Dancheva</LastName>
        <affiliation locale="en_US">Sector of Disaster Medicine, Medical University, Pleven, Bulgaria.</affiliation>
      </Author>
      <Author>
        <FirstName>Lyudmil</FirstName>
        <LastName>Terziev</LastName>
        <affiliation locale="en_US">Sector of Clinical Immunology and Allergology, Medical University, Pleven, Bulgaria</affiliation>
      </Author>
      <Author>
        <FirstName>Veneta</FirstName>
        <LastName>Shopova</LastName>
        <affiliation locale="en_US">Sector of Disaster Medicine, Medical University, Pleven, Bulgaria.</affiliation>
      </Author>
      <Author>
        <FirstName>Galya</FirstName>
        <LastName>Stavreva</LastName>
        <affiliation locale="en_US">Sector of Clinical and Experimental Pharmacology, &#xA0;Medical University, Pleven, Bulgaria</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">We aimed to study the MnTnHex-2-PyP effect on some markers of lung antioxidant defence system in mice asthma model.The study was carried out on 28 C57B1/6 mice divided into four treatment groups: group 1 - controls; group 2 - injected and inhaled with ovalbumin; group 3 - treated with MnTnHex-2-PyP and inhaled with phosphate buffered saline; group 4 - injected with ovalbumin and MnTnHex-2-PyP but also inhaled with ovalbumin. On days 24, 25 and 26, mice from groups 1 and 2 were inhaled with PBS for 30 min, and those from groups 2 and 4 were given a 1% ovalbumin solution. One hour before inhalation, and 12 hours later the animals from groups 1 and 2 were injected i.p. with 100 &#x3BC;l PBS, and those from groups 3 and 4 received a 100 &#x3BC;l MnTnHex-2-PyP solution in PBS, &#x441;ontaining 0,05mg/kg. The animals were killed by exsanguination 48 hours after the last inhalation for obtaining a lung homogenate. The activities of superoxide dismutase, catalase, glutathione peroxidase and the non-protein sulphhydryl group content in the lung homogenate were investigated. Ovalbumin decreased the activities of superoxide dismutase (p=0.01), catalase (p=0.002), glutathione peroxidase and non-protein sulphhydryl groups content (p&lt;0.001) in comparison to controls. In group 4 (ovalbumin and MnTnHex-2-PyP) the activities of superoxide dismutase (p=0.044), catalase (p=0.045), glutathione peroxidase (p=0.002), and the non-protein sulphhydryl groups content (p&lt;0.001) were significantly increased compared to ovalbumin (group 2).MnTnHex-2-PyP restored the activities of basic enzymes in the lung antioxidant defence system in ovalbumin-induced asthma mice model, 48 hours after the last nebulization.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/544</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/544/506</pdf_url>
  </Article>
</Articles>
